Quark Biosciences Inc. today announced that it received the iF DESIGN AWARD 2021 with NextAmp™ Analysis System in the Product discipline. The NextAmp™ Analysis System is an innovative molecular diagnostic platform for precision medicine, a market that’s seen the demand for multi-biomarker analysis grow, and
QuarkBio has received the CE IVD mark for our Q Station™ Dx 1000, for use as an in vitro diagnostic (IVD) device in the European Union. With the CE IVD mark, we are poised for the European market and eventually other global regions.
QuarkBio’s DigiChip™ SARS-CoV-2 Assay Kit has received manufacturing approval from Taiwan Ministry of Health and Welfare as part of the "Approved List of Medical Device Manufacturing Application for SARS-CoV-2". The approval period is from November 23, 2020, to December 31, 2021. Approval number: 1096818270; Approved
Quark Biosciences, Inc. has received certification from the SGS on July 17, 2020, that our quality system meets the ISO 13485 Standard for Medical Device and Diagnostic Product Development and Manufacturing. Audit scope: design, develop, manufacture, and sell nucleic acid analysis systems - analysis and
QuarkBio’s NextAmp™ Analysis System¹ have recently appeared in the Clinical Rheumatology² article by Dr. Yu-Juh Su of Kaoshiung Chang Gung Memorial Hospital (CGMH) on the early detection of psoriatic arthritis (PSA) and the challenge it poses to rheumatologists. To facilitate early detection of PSA among patients with psoriasis
Happy Mid Autumn Festival from QuarkBio! Our PanelChip® family hopes that everyone will have a festive and fun-filled holiday with family and loved ones. Last week we received some exciting news: our abstract was accepted at this year's ESMO Asia for an oral presentation for
Happy Father's Day from QuarkBio to all the supermen in the world! A mysterious new "SuperChip" will be joining our PanelChip® family soon, can anyone guess "who" it is?
Happy Mother's Day from QuarkBio to all the superwomen that provide the base support for their family and friends! Our QuarkBio family of products will soon be increasing its size once again, as we launch a new miRNA-based product that will help create more superwomen
Happy Chinese New Year from QuarkBio! We're looking forward to a prosperous Year of the Pig as PanelStation™ reception in China has been overwhelmingly positive, as it allows users to translate research findings into ready-to-use products in clinical settings. Additionally, plans to obtain ISO13485 certification
We have officially launched our PanelStation™ V1.0! Our Christmas miracle will be sailing across the Taiwan strait in January to different locations in China where we will be translating discoveries into clinical diagnostic products with local researchers. We aim to develop a series of precision